ROOM SORRENTO - AUGUST 30
- Systematic Review for the new ASMBS/IFSO Guidelines - Antonio Vitiello
- Metabolic and Bariatric Surgery in Class 1 Obesity in Asian Population - Asim Shabbir
- Metabolic/Bariatric Surgery in Class I Obesity in Patients with Type 2 Diabetes - Francesco Rubino
- MBS Class II obesity without obesity complications: what is the evidence? - Khaled Gawdat
- Expanding the MBS guidelines MBS for high-risk patients Elderly, Transplant and Cardiac patients - Wendy A. Brown
- MBS options in a patient with Class I/II Obesity & a large abdominal wall hernia - Lilian Kow
- Obesity, Bariatric Surgery and Cancer - Raul J. Rosenthal
- High Risk Patients: Cirrhosis, Class V Obesity (BMI > 60), Heart Failure, Renal Failure: Systematic Review For New Ifso/asmbs Guidelines - Giacomo Piatto
- NASH Cirrhosis: (When) To operate or (Better) Not to Operate - Ali Aminian
- Metabolic/Bariatric Surgery (MBS) in BMI>60 Operation – Strategy & Perioperative Risk - Shanu N. Kothari
- Treating Obesity to Promote Heart Health - Lee M. Kaplan
- MBS as a bridge to heart transplantation: Results, Limitations, Risks, Perspectives - Gerhard Prager
- New Frontier : Obesity, Bariatric Surgery and Chronic Kidney Disease (CKD) - Raul J. Rosenthal
- MBS and Kidney transplantation: Timing and Outcomes - Raul J. Rosenthal
- Older Population. Systematic review for the new ASMBS/ IFSO Guidelines - Giovanni Merola
- Elderly patients: real life indication outside the 2022 IFSO/ASMBS guidelines - Abdelrahman A. Nimeri
- Older population. Management of Sarcopenia in Bariatric Patients - Maurizio De Luca
- Pediatrics/Adolescents Systematic Review for IFSO/ASMBS Guidelines - Giacomo Piatto
- Pediatric/ Adolescents. Real life indications beyond the Guidelines - J. Pujol Rafols
- NPediatric/ Adolescents and MBS. The best approach - Wendy A. Brown
- Mechanisms of action of obesity surgery - Alex Miras
- Mechanism of drugs - Carel le Roux
- Metabolic Adaptation and Defense of Body Fat Mass:Implications for Obesity Treatment - Lee M. Kaplan